SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-22-170610
Filing Date
2022-06-09
Accepted
2022-06-09 07:09:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 d307279d425.htm 425 47873
2 GRAPHIC g307279dsp1a.jpg GRAPHIC 2517
3 GRAPHIC g307279dsp1b.jpg GRAPHIC 5278
  Complete submission text file 0001193125-22-170610.txt   60717
Mailing Address C/O OAKTREE CAPITAL MANAGEMENT, L.P. 333 S. GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071
Business Address C/O OAKTREE CAPITAL MANAGEMENT, L.P. 333 S. GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071 213-830-6300
Oaktree Acquisition Corp. II (Subject) CIK: 0001820931 (see all company filings)

IRS No.: 981551592 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39526 | Film No.: 221004925
SIC: 6770 Blank Checks

Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Filed by) CIK: 0001898416 (see all company filings)

IRS No.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)